Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT00718393
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of definite or probable ALS by the El Escorial Criteria
* Participants must be medically able to undergo the study procedures
* Subjects must have a registered nurse who can administer the drug daily and also inspect the IV site
* Not Pregnant
* Willing to pay for the cost of drug, administration, and safety testing
* Able to give informed consent
Exclusion Criteria:
* Patients who are not diagnosed with ALS by a physician
* Patients unable to give informed consent
* Patients who have a history of sensitivity to cephalosporin or penicillin antibiotics (such as Ancef, Keflex, Ceclor, Ceftin, Lorabid, Suprax, or Fortaz).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT00718393
Study Brief:
Protocol Section:
NCT00718393